Zimmer Biomet (ZBH) Procedure Recovery Aids Amid Macro Woes

Despite a sizable day rate headwind and difficult year-over-year comps in the first quarter, U.S. sales rose 3.7% year over year. Since the beginning of 2024, procedure volume has been very strong in both Knees and Hips, banking on an improved market scenario. International sales grew 5.4% year over year at a constant exchange rate. All regions benefited primarily from continued growth in the Knee category as well as strong commercial execution and new product uptake. Zimmer Biomet (ZBH) is witnessing volum ...